The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers

被引:4
|
作者
Jamalidoust, Marzieh [1 ]
Eilami, Owrang [2 ]
Ashkan, Zahra [3 ]
Ziyaeyan, Mazyar [1 ]
Aliabadi, Nasrin [1 ]
Habibi, Mohammad [4 ]
机构
[1] Shiraz Univ Med Sci, Namazi Hosp, Prof Alborzi Clin Microbiol Res Ctr, Dept Virol, Shiraz 7193711351, Iran
[2] Shiraz Univ Med Sci, Dept Family Med & Infect Dis, Shiraz, Iran
[3] Shahrekord Univ, Fac Basic Sci, Dept Biol, Shahrekord, Iran
[4] Shiraz Univ Med Sci, Stat & Informat Technol Management, Shiraz, Iran
关键词
Breakthrough infection; Healthcare worker; Natural infection; SARS-C0V-2; Vaccination;
D O I
10.1186/s12985-023-02156-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background/AimsThe aim of this study was to determine the rate of natural and breakthrough infection and related symptoms of Covid-19 amongst Iranian healthcare workers (HCWs) who were vaccinated by different non-mRNA-based vaccines at peak points.MethodsIn this cross-sectional study, the RT-PCR test was performed for a total of 10,581 HCWs suspicious of Covid-19 infection. For each HCW, the frequency of SARS-CoV-2 infection and the time of transmission based on vaccination administration time and schedule were examined during different waves of the pandemic. Based on these findings, the study patients were divided into three groups: natural, natural/breakthrough, and breakthrough.ResultsIn total, 53% of the HCWs were exposed to SARS-CoV-2 infection between 1 and 5 times within two years after the current pandemic, while 20.7% and 32.3% experienced natural and breakthrough SARS-CoV-2 infection, respectively. Only 6% of the breakthrough-infected HCWs had naturally contracted SARS-CoV-2 infection during the initial waves. The highest natural peaks of infection occurred during the interval administration of the first and second dose of the first vaccination series, while the single highest peak of breakthrough infection belonged to the Omicron wave. It occurred simultaneously with the administration of the third vaccination dose. On the other hand, the highest rate of reinfection was observed amongst people who had received the Sinopharm and Bharat vaccines full-doses.ConclusionThis study compared the clinical differences between the two peaks of Omicron and Delta. This study indicates the rates of natural and breakthrough SARS-CoV-2 infections according to vaccination schedules and different waves of the pandemic.
引用
收藏
页数:8
相关论文
共 36 条
  • [31] Coronavirus Disease 2019 [COVID-19] Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study (vol 75, Pg e683, 2022)
    Yamamoto, S.
    Mizoue, Tetsuya
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (06) : 1159 - 1159
  • [32] Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms
    Kadali, Renuka Ananth Kalyan
    Janagama, Ravali
    Peruru, Sharanya
    Gajula, Viswanath
    Madathala, Rajasekhar R.
    Chennaiahgari, Nikhita
    Malayala, Srikrishna V.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (07) : 4420 - 4429
  • [33] Does enhanced educational intervention reduce breakthrough infection and mental health problems via improving acceptance of COVID-19 booster shots in Chinese non-healthcare workers: A randomized controlled trial?
    Tse, Lap Ah
    Wang, Feng
    Mo, Phoenix Kit Han
    Wan, Cherry Choi Miu
    Tang, Natalie Hiu Yu
    Yang, Shuyuan
    Dong, Dong
    Ho, Kin Fai
    Wong, Samuel Yang-shan
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2025, 18 (05)
  • [34] Assessment of Post-Vaccination Antibody Response Eight Months after the Administration of BNT1622b2 Vaccine to Healthcare Workers with Particular Emphasis on the Impact of Previous COVID-19 Infection
    Wolszczak-Biedrzycka, Blanka
    Bienkowska, Anna
    Dorf, Justyna
    VACCINES, 2021, 9 (12)
  • [35] COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
    Luxi, Nicoletta
    Giovanazzi, Alexia
    Capuano, Annalisa
    Crisafulli, Salvatore
    Cutroneo, Paola Maria
    Fantini, Maria Pia
    Ferrajolo, Carmen
    Moretti, Ugo
    Poluzzi, Elisabetta
    Raschi, Emanuel
    Ravaldi, Claudia
    Reno, Chiara
    Tuccori, Marco
    Vannacci, Alfredo
    Zanoni, Giovanna
    Trifiro, Gianluca
    DRUG SAFETY, 2021, 44 (12) : 1247 - 1269
  • [36] COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
    Nicoletta Luxi
    Alexia Giovanazzi
    Annalisa Capuano
    Salvatore Crisafulli
    Paola Maria Cutroneo
    Maria Pia Fantini
    Carmen Ferrajolo
    Ugo Moretti
    Elisabetta Poluzzi
    Emanuel Raschi
    Claudia Ravaldi
    Chiara Reno
    Marco Tuccori
    Alfredo Vannacci
    Giovanna Zanoni
    Gianluca Trifirò
    Drug Safety, 2021, 44 : 1247 - 1269